Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

9.39
Delayed Data
As of Feb 26
 -0.37 / -3.79%
Today’s Change
4.58
Today|||52-Week Range
18.73
+61.90%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close9.76
Today’s open9.87
Day’s range9.31 - 9.87
Volume107,433
Average volume (3 months)52,644
Market cap$108.3M
Dividend yield--
Data as of 02/26/2015

Growth & Valuation

Earnings growth (last year)+447.62%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
TLOGTetraLogic Pharmaceu...-0.04-0.82%
AQXPAquinox Pharmaceutic...-0.50-4.86%
NVETNexvet Biopharma plc+0.04+0.40%
OCRXOcera Therapeutics I...+0.10+1.77%
Data as of 02/26/2015

Financials

Last reporting dateFebruary 27, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$17.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account